1. Unit startpage
  2. Employees
  3. Ana Paola Lombardi
Bilde av Lombardi, Ana Paola
Bilde av Lombardi, Ana Paola
Over engineer Department of Medical Biology ana.lombardi@uit.no 41236358 Tromsø

Ana Paola Lombardi

Job description

My main focus is to find good and safe methodologies that can answer the researchers' questions. I am responsable for the Cellular Laboratory where I perform functional studies with different cancer cells. I also develop IHC and Multiplexing to detect special biomarkers with Discovery Ultra instrument  for clinical studies and with patient samples from several hospitals in Norway.

  • Dagny Førde, Thomas Karsten Kilvær, Mona Irene Pedersen, Ana Paola Lombardi, Irene D’arsiè, Erna-Elise Paulsen et al.:
    Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
    Frontiers in Oncology 25. September 2025 DOI
  • Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Ana Paola Lombardi, Mette Pøhl et al.:
    Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
    Frontiers in Oncology 2023 DOI / ARKIV
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Lise Martine Ingebriktsen, Roy M. Bremnes et al.:
    High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Scientific Reports 2021 DOI / ARKIV
  • Masoud Tafavvoghi, Erna-Elise Paulsen, Falah Jabar Rahim, Sigve Andersen, Ana Paola Lombardi, Elin Richardsen et al.:
    51P Deep learning-based detection of non-angiogenic growth patterns in early-stage lung cancer
    ESMO Real World Data and Digital Oncology 01. November 2025 DOI

    • The 50 latest publications is shown on this page. See all publications in Cristin here →

    Research interests

    My interest in research is to find efficient methods that can identify important biomarkers. I also have a special feeling for the pharmacological area, as I like to understand the molecular mechanisms that contribute to the different cancer prognosis.

    Teaching

    Ph.D.Science, São Paulo Federal University, 2018. Pharmacology; Estrogen pharmacology in prostate cancer.
    M.A., Science, São Paulo Federal University, 2013. Pharmacology; Estrogen pharmacology in prostate cancer.
    B.S, Biology, São Paulo Metodista University, São Paulo, SP, 2006.

    Teaching Degree, São Paulo Metodista University, São Paulo, SP, 2006 


    Member of research group

    Translational Cancer Research Group (TCRG)   English content